49 results
Categories
Human Remove Human filter
Veterinary Remove Veterinary filter
Corporate Remove Corporate filter
Type of content
News Remove News filter
Responsible body
PRAC Remove PRAC filter
Patient safety
Yes Remove Yes filter
-
List item
News: EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
PRAC, Last updated: 03/11/2022 -
List item
News: COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets
PRAC, Last updated: 19/03/2021 -
List item
Press release: EMA review of Zinbryta confirms medicine's risks outweigh its benefits
PRAC, Last updated: 18/05/2018 -
List item
Press release: New study suggests risk of birth defects in babies born to women on HIV medicine dolutegravir
PRAC, Last updated: 18/05/2018 -
List item
Press release: EMA reviewing risk of dosing errors with methotrexate
PRAC, Last updated: 13/04/2018 -
List item
Press release: Prostate cancer medicine Xofigo must not be used with Zytiga and prednisone/prednisolone
PRAC, Last updated: 09/03/2018 -
List item
Press release: EMA urgently reviewing multiple sclerosis medicine Zinbryta following cases of inflammatory brain disorders
PRAC, Last updated: 02/03/2018 -
List item
Press release: PRAC recommends new measures to avoid valproate exposure in pregnancy
PRAC, Last updated: 09/02/2018 -
List item
Press release: Women taking Esmya for uterine fibroids to have regular liver tests while EMA review is ongoing
PRAC, Last updated: 09/02/2018 -
List item
Press release: EMA starts new review of hydroxyethyl-starch containing medicines
PRAC, Last updated: 27/10/2017 -
List item
Press release: Review of flupirtine-containing medicines started
PRAC, Last updated: 27/10/2017 -
List item
Press release: PRAC recommends further restrictions for multiple sclerosis medicine Zinbryta due to risk of serious liver damage
PRAC, Last updated: 27/10/2017 -
List item
Press release: PRAC concludes review of Zydelig and issues updated recommendations for use
PRAC, Last updated: 08/07/2016 -
List item
Press release: EMA recommends new safety measures for Zydelig
PRAC, Last updated: 18/03/2016 -
List item
Press release: Fluoroquinolone and quinolone antibiotics: PRAC recommends new restrictions on use following review of disabling and potentially long-lasting side effects
PRAC, Last updated: 05/10/2018 -
List item
Press release: Suspension of fenspiride medicines due to potential risk of heart rhythm problems
PRAC, Last updated: 15/02/2019 -
List item
Press release: Use of multiple sclerosis medicine Lemtrada restricted while EMA review is ongoing
PRAC, Last updated: 12/04/2019 -
List item
Press release: Restrictions in use of Xeljanz while EMA reviews risk of blood clots in lungs
PRAC, Last updated: 17/05/2019 -
List item
Press release: Withdrawal of marketing authorisations for fenspiride medicines
PRAC, Last updated: 17/05/2019 -
List item
Press release: PRAC recommends new measures to avoid dosing errors with methotrexate
PRAC, Last updated: 12/07/2019 -
List item
Press release: Four-week limit for use of high-strength estradiol creams
PRAC, Last updated: 04/10/2019 -
List item
Press release: EMA suspends Picato as a precaution while review of skin cancer risk continues
PRAC, Last updated: 17/01/2020 -
List item
Press release: PRAC confirms four-week limit for use of high-strength estradiol creams
PRAC, Last updated: 17/01/2020 -
List item
Press release: Restrictions in use of cyproterone due to meningioma risk
PRAC, Last updated: 14/02/2020 -
List item
Press release: Suspension of ulipristal acetate for uterine fibroids during ongoing EMA review of liver injury risk
PRAC, Last updated: 13/03/2020